About Humana Inc.
https://www.humana.comHumana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals.
CEO
James A. Rechtin
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1991-08-01 | Forward | 3:2 |
| 1984-02-01 | Forward | 6:5 |
ETFs Holding This Stock
Summary
Showing Top 3 of 790
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Jefferies
Buy
Guggenheim
Buy
Mizuho
Outperform
Bernstein
Outperform
RBC Capital
Outperform
Oppenheimer
Outperform
Grade Summary
Showing Top 6 of 17
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:14.16M
Value:$3.88B
DODGE & COX
Shares:11.34M
Value:$3.11B
BLACKROCK INC.
Shares:10.97M
Value:$3.01B
Summary
Showing Top 3 of 1,282
About Humana Inc.
https://www.humana.comHumana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $32.65B ▲ | $32.52B ▲ | $195M ▼ | 0.6% ▼ | $1.62 ▼ | $480M ▼ |
| Q2-2025 | $32.39B ▲ | $31.65B ▲ | $545M ▼ | 1.68% ▼ | $4.52 ▼ | $1.11B ▼ |
| Q1-2025 | $32.11B ▲ | $30.42B ▲ | $1.24B ▲ | 3.87% ▲ | $10.31 ▲ | $2.07B ▲ |
| Q4-2024 | $29.21B ▼ | $30.07B ▲ | $-693M ▼ | -2.37% ▼ | $-5.75 ▼ | $-458M ▼ |
| Q3-2024 | $29.4B | $28.75B | $480M | 1.63% | $3.99 | $1.06B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $5.39B ▲ | $49.72B ▼ | $31.14B ▼ | $18.52B ▲ |
| Q2-2025 | $4.04B ▼ | $50.36B ▼ | $32.06B ▼ | $18.23B ▲ |
| Q1-2025 | $4.25B ▲ | $50.93B ▲ | $33.11B ▲ | $17.75B ▲ |
| Q4-2024 | $2.22B ▼ | $46.48B ▼ | $30.03B ▼ | $16.38B ▼ |
| Q3-2024 | $5.12B | $50.01B | $32.38B | $17.57B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $194M ▼ | $971M ▼ | $980M ▲ | $-603M ▲ | $1.35B ▲ | $836M ▼ |
| Q2-2025 | $543M ▼ | $1.27B ▲ | $347M ▲ | $-1.83B ▼ | $-210M ▼ | $1.16B ▲ |
| Q1-2025 | $1.24B ▲ | $331M ▲ | $314M ▲ | $1.38B ▲ | $2.03B ▲ | $236M ▲ |
| Q4-2024 | $-686M ▼ | $-528M ▼ | $-63M ▲ | $-2.3B ▼ | $-2.9B ▼ | $-682M ▼ |
| Q3-2024 | $480M | $1.86B | $-1.47B | $-770M | $-385M | $1.73B |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 CenterWell Segment | $5.13Bn ▲ | $5.09Bn ▼ | $5.54Bn ▲ | $5.88Bn ▲ |
 Insurance Segment | $28.17Bn ▲ | $30.94Bn ▲ | $31.09Bn ▲ | $31.19Bn ▲ |
CEO
James A. Rechtin
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 1991-08-01 | Forward | 3:2 |
| 1984-02-01 | Forward | 6:5 |
ETFs Holding This Stock
Summary
Showing Top 3 of 790
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Jefferies
Buy
Guggenheim
Buy
Mizuho
Outperform
Bernstein
Outperform
RBC Capital
Outperform
Oppenheimer
Outperform
Grade Summary
Showing Top 6 of 17
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:14.16M
Value:$3.88B
DODGE & COX
Shares:11.34M
Value:$3.11B
BLACKROCK INC.
Shares:10.97M
Value:$3.01B
Summary
Showing Top 3 of 1,282